Impact of Weight on Clinical Outcomes of Edoxaban Therapy in Atrial Fibrillation Patients Included in the ETNA-AF-Europe Registry

Impact of Weight on Clinical Outcomes of Edoxaban Therapy in Atrial Fibrillation Patients Included in the ETNA-AF-Europe Registry

Background: Extremes of body weight may alter exposure to non-vitamin K antagonist oral anticoagulants and thereby impact clinical outcomes. This ETNA-AF-Europe sub-analysis assessed 1-year outcomes in routine care patients with atrial fibrillation across a range of body weight groups treated with e...

Full description

Bibliographic Details
Main Authors: Giuseppe Boriani, Raffaele De Caterina, Marius Constantin Manu, José Souza, Ladislav Pecen, Paulus Kirchhof
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Journal of Clinical Medicine
Subjects:
atrial fibrillation
edoxaban
weight
registry
effectiveness
safety
Online Access:https://www.mdpi.com/2077-0383/10/13/2879

Internet

https://www.mdpi.com/2077-0383/10/13/2879

Similar Items